Concepedia

Author

Josephine Schultz

Fox Chase Cancer CenterORCID

Also Known As

J Schultz, J. Schultz, Josephine Schultz

19

Publications

281

Citations

8

H-Index

37

Concepts

All Affiliations

Fox Chase Cancer CenterDana-Farber Cancer InstituteChristchurch HospitalUniversität HamburgGeorgetown University
JS

About

Josephine Schultz is an author at Fox Chase Cancer Center specializing in medicine, oncology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

164

2

Immunology

2

2

59

3

Health Sciences

1

1

54

4

Allergy

1

1

19

5

Pathology

1

1

40

Josephine Schultz

×

8

Publications

257

Citations

8

H-Index

YearCitations

Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer.

Bruce J. Giantonio, R. Katherine Alpaugh, Josephine Schultz,

Journal of Clinical Oncology

1997

82

A randomized trial of first-line irinotecan/fluoropymidine combinations with or without celecoxib in metastatic colorectal cancer (BICC-C)

Charles S. Fuchs, J. Marshall, Edith P. Mitchell,

Journal of Clinical Oncology

2006

54

Superantigen-targeted therapy: phase I escalating repeat dose trial of the fusion protein PNU-214565 in patients with advanced gastrointestinal malignancies.

R. Katherine Alpaugh, Josephine Schultz, C McAleer,

PubMed

1998

40

Updated results of BICC-C study comparing first-line irinotecan/fluoropymidine combinations with or without celecoxib in mCRC: Updated efficacy data

Charles S. Fuchs, John L. Marshall, E. Mitchell,

Journal of Clinical Oncology

2007

28

Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatment

John I. Clark, R. Katherine Alpaugh, Margaret von Mehren,

Cancer Immunology Immunotherapy

1997

19

Efficacy and moderators of metacognitive training for depression in older adults (MCT-Silver): A randomized controlled trial

Brooke C. Schneider, Ruth Veckenstedt, Evangelos Karamatskos,

Journal of Affective Disorders

2023

13

Improving adherence to unguided Internet-based therapy for obsessive-compulsive disorder: A randomized controlled trial

Lena Jelinek, Johanna Schröder, Lara Bücker,

Journal of Affective Disorders

2023

11

Safety and efficacy of first-line irinotecan/fluoropymidine combinations in mCRC patients >65 years compared with those ≤65: The BICC-C study

José Barrueco, J. Marshall, E. Mitchell,

Journal of Clinical Oncology

2007

10

Page 1